Bz-Lys-OMe·HCl CAS:14280-01-4

Bz-Lys-OMe·HCl inoshandiswa zvakanyanya mukugadzirwa kwepeptide yakasimba, ichiita basa rakakosha mukugadzira mapeptide ane ma sequences chaiwo uye ma structure features. Inobatsira mukubatanidzwa kwemaamino acids akasarudzwa, zvichibvumira kuungana kwema peptide akaomarara nenzira chaiyo uye inoshanda. Kuenderana kwekomputa iyi nema coupling reagents akasiyana-siyana, resin supports, uye mapoka anodzivirira kunoita kuti ive sarudzo inoshanda pakuvaka ma peptide structures akasiyana-siyana akagadzirirwa zvinodiwa pakutsvagisa. Uyezve, Bz-Lys-OMe·HCl inowana mashandisirwo mukugadzira mishonga mitsva ine peptide, uko kunaka kwayo kwakasimba uye kuvimbika kwakakosha pakuona kuti ma synthetic processes anodzokororwa uye kugadzirwa kwe peptide products yakachena. Mukuwana nekugadzira mishonga, kugadzirwa kwakarurama kwe peptide analogs uye derivatives kwakakosha pakuongorora hukama hwe structure-activity uye kugadzirisa hunyanzvi hwekurapa. Naizvozvo, Bz-Lys-OMe·HCl inoshanda sechishandiso chakakosha kune masayendisiti ari kuita dhizaini uye kugadzirwa kwe peptide-based compounds ine mashandisirwo anogona kuitwa ne pharmacological. Muchidimbu, kushanda kwakakura kweBz-Lys-OMe·HCl mukugadzirwa kwepeptide, pamwe chete nekuenderana kwayo nemaitiro akajairwa emurabhoritari, kunoita kuti ive chinhu chakakosha muzvishandiso zvevaongorori nevanoongorora mishonga vanoshanda muminda yemakemikari echisikigo, kutsvagisa mishonga, uye kugadzirwa kwemishonga.